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Results: There was no difference in initial response for NET treated with TAE versus RE (53% vs 59% CR or PR, p=0.66). Initial response was higher for TAE using particles <100 μm versus TAE using only particles ≥100 μm (64% vs 42%, p=0.007). Multivariate logistic regression showed that use of particles <100 μm, and liver <50% replaced with tumor were independent predictors of a better initial response rate. For well to moderately differentiated NET, median OS after initial locoregional therapy was 55 months for both TAE and RE (p=0.91). For poorly differentiated or undifferentiated NET, median OS after initial locoregional therapy was 13 months for TAE and 5 months for RE (p=0.076). There was no significant difference in survival between TAE patients treated with <100 μm versus only ≥100 μm particles. Multivariate Cox proportional hazards model showed that well to moderately differentiated NET, and liver <50% replaced by tumor were the only independent predictors of improved OS.
Conclusion: NET patients treated with TAE have the same initial response and overall survival, compared to RE. NET patients treated with TAE using particles <100 μm had better initial response, but the same overall survival, compared to TAE using only particles ≥100 μm. 
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